secwatch.observer — SEC 8-K summary
======================================

Issuer:     Compass Therapeutics, Inc. (CMPX)
CIK:        0001738021
Form:       8-K
Filed at:   2022-04-26T23:59:59+00:00
Accession:  0001171843-22-002790
Event type: leadership
Sentiment:  positive
Materiality: 0.55
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Compass Therapeutics appoints Chiniara and Gray to board; Toledano departs
--------------------------------------------------------------------------

- Ellen Chiniara (former Alexion Chief Legal Officer) and Mary Ann Gray (Gray Strategic Advisors) join as Class I directors.
- Both deemed independent; Chiniara also appointed to Nominating/Governance and Compensation committees.
- Each non-employee director receives $45K cash retainer and initial option on 45,000 shares vesting over four years.
- Miranda Toledano will not stand for reelection at May 24, 2022 annual meeting; no disagreement cited.
- Appointments aim to support pipeline advancement and shareholder value creation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1738021/000117184322002790/0001171843-22-002790-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1738021/000117184322002790/f8k_042522.htm
  HTML page:      https://secwatch.observer/filing/0001171843-22-002790

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer